Product ID:TECHNESCAN HDP
MSDS Date:01/01/1997
FSC:6505
NIIN:00F054703
MSDS Number: CGHNX

MALLINCKRODT MEDICAL INC

2703 WAGNER PLACE
MARYLAND HEIGHTS, MO 63043-3421
US

Emergency Phone: 314-770-7800

Info Phone: 314-770-7800/314-895-2000

Cage: FO650

MALLINCKRODT MEDICAL INC

MARYLAND HEIGHTS, MO 63043-3421 US

Telephone: 314-770-7800/314-895-2000

Cage: FO650

STANNOUS CHLORIDE

CAS: 7772-99-8

RTECS: XP8700000

Fraction By Weight: 0.9%

OSHA PEL 2 MG/CUM

ACGIH TLV: 2 MG/CUM

2,5-DIHYDROXYBENZOIC ACID

CAS: 490-79-9

RTECS: LY3850000

Fraction By Weight: 2.4%

OXIDRONATE SODIUM

Fraction By Weight: 9.2%

SODIUM CHLORIDE *97-4*

CAS: 7647-14-5

RTECS: VZ4725000

Fraction By Weight: 87.5%

SODIUM PERTECHNETATE TC 99 *97-4*

CAS: 23288-60-0

Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:DUE TO SMALL QUANTITIES PRESENT IN
EACH CONTAINER, NO ADVERSE HEALTH EFFECTS ARE EXPECTED TO OCCUR
FROM EXPOSURE.
Explanation of Carcinogenicity:NONE

First Aid:SKIN: WASH W/SOAP & WATER. EYES: WASH THOROUGHLY W/RUNNING
WATER. OBTAIN MEDICAL ATTENTION IN ALL CASES.

Flash Point:NONFLAMMABLE
Extinguishing Media:USE ANY MEANS SUITABLE FOR EXTINGUISHING
SURROUNDING FIRE.
Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING & NIOSH-APPROVED
SELF CONTAINED BREATHING APPARATUS W/FULL FACEPIECE OPERATED IN THE
PRESSURE DEMAND/OTHER POSITIVE PRESSURE MODE.
Unusual Fire/Explosion Hazard:WHEN HEATED TO DECOMPOSITION, SUBSTANCE
MAY EMIT OXIDES OF CARBON & CORROSIVE FUMES OF HYDROCHLORIC ACID.

Spill Release Procedures:IF ANY LOSS/RELEASE OF THE RADIOACTIVE
CONTENTS OCCURS, NOTIFY THE RADIATION SAFETY DEPT & MALLINCKRODT.
ALL CLEANUP OPERATIONS SHOULD BE PERFORMED ACCORDING TO THE
STANDARD OPERATING PROCEDURES.

Handling and Storage Precautions:STORE AT 59-85F. HANDLING TIME SHOULD
BE KEPT TO A MINIMUM. USE HANDLING DEVICES SUCH AS SYRINGE SHIELDS
& TONGS. READ PACKAGE INSERT PRIOR TO USE.
Other Precautions:BECAUSE THIS PRODUCT IS INTENDED FOR USE BY
HOSPITAL/CLINIC PATIENTS, IT IS EXPECTED TO BE TREATED BY STANDARD
WASTEWATER TREATMENT FACILITIES W/NO ADVERSE ENVIRONMENTAL IMPACTS.
RADIOACTIVE DRUGS MUS T BE HANDLED BY QUALIFIED PERSONNEL.

Respiratory Protection:NOT REQUIRED
Ventilation:NOT REQUIRED
Protective Gloves:REQUIRED
Eye Protection:SAFETY GLASSES
Other Protective Equipment:CLEAN BODY-COVERING CLOTHING.
Supplemental Safety and Health
THE VIAL CONTAINING THE DRUG SHOULD BE KEPT W/IN ITS CONTAINER/W/IN
HEAVIER SHIELDING. AVOID CONTACT W/THE RADIOACTIVE CONTENTS WHICH
WOULD CAUSE UNNECESSARY EXPOSURE TO RADIATION.

Boiling Pt:B.P. Text:212F
Melt/Freeze Pt:M.P/F.P Text:32F
Solubility in Water:COMPLETE
Appearance and Odor:SMALL, DRY, WHITE CRYSTALS CLINGING TO INSIDE OF 6
ML GLASS VIALS W/NO ODOR

Stability Indicator/Materials to Avoid:YES
Stability Condition to Avoid:HEATING
Hazardous Decomposition Products:OXIDES OF CARBON, FUMES OF
HYDROCHLORIC ACID

Waste Disposal Methods:IF MEDICAL WASTE IS INVOLVED, SUCH AS BLOOD,
BLOOD PRODUCTS/SHARPS, THE WASTE MUST BE HANDLED AS A BIOHAZARD &
DISPOSED OF IAW/LOCAL, STATE & FEDERAL REGULATIONS. RADIOACTIVE
MATERIAL UN2982.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.